Ouro Medicines Takes a Bold Step in Autoimmune Treatment with New Clinical Trial for OM336 Ouro Medicines announces plans for a clinical trial of OM336, aimed at tackling autoimmune cytopenias. Exciting case studies emerge in NEJM, advocating the potential of this therapy.

Ouro Medicines Takes a Bold Step in Autoimmune Treatment with New Clinical Trial for OM336 #United_States #San_Francisco #Ouro_Medicines #OM336 #Autoimmune_Cytopenias